A key pharmaceutical industry case argued just last week before the Supreme Court ended Monday morning with a loss for the industry. The Court announced it was divided 4-4 in the case Warner-Lambert v. Kent, a split that resulted from the recusal of Chief Justice John Roberts Jr. At issue in the case was whether federal law pre-empts a Michigan statute that allows suits against drug makers when plaintiffs can show that the manufacturers deliberately defrauded the Food and Drug Administration.
Roberts' Recusal Is Poison Pill for Drug Case Before Supreme Court
March 4, 2008
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.